Ritalin la and Paleness - a phase IV clinical study of FDA data

Summary:

Paleness is reported as a side effect among people who take Ritalin la (methylphenidate hydrochloride), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Ritalin, and have Disturbance in attention.

The phase IV clinical study analyzes which people have Paleness when taking Ritalin la. It is created by eHealthMe based on reports of 2,254 people who have side effects when taking Ritalin la from the FDA, and is updated regularly.

What is Ritalin la?

Ritalin la has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 2,563 Ritalin la users. Check the latest studies of Ritalin la.

What is Paleness?

Paleness (unusual lightness of skin colour) is found to be associated with 1,551 drugs and 2,119 conditions by eHealthMe. Check the latest studies of Paleness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

2,254 people reported to have side effects when taking Ritalin la.
Among them, 14 people (0.62%) have Paleness.

Among these 14 people:

How long have people been on Ritalin la when they have Paleness? *

What is the gender of people who have Paleness when taking Ritalin la? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Paleness when taking Ritalin la? *

What are other drugs people take besides Ritalin la? *

What are other side effects people have besides Paleness? *

Dizziness: 6 people, 42.86%
Nausea (feeling of having an urge to vomit): 5 people, 35.71%
Hyperhidrosis (abnormally increased sweating): 4 people, 28.57%
Headache (pain in head): 4 people, 28.57%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 4 people, 28.57%
Feeling Abnormal: 4 people, 28.57%
Arrhythmias (irregular heartbeat): 3 people, 21.43%
Agitation (state of anxiety or nervous excitement): 3 people, 21.43%
Nervousness: 2 people, 14.29%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 14.29%

What are the existing conditions these people have? *

Disturbance In Attention: 2 people, 14.29%
Psychomotor Hyperactivity (feelings of extreme restlessness): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.14%
Dyspraxia (partial loss of the ability to co-ordinate and perform skilled, purposeful movements and gestures with normal accuracy): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ritalin la and have Paleness?

- Check whether Paleness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ritalin la:

Ritalin la (2,563 reports)

Paleness treatments and more:

Paleness (34,670 reports)

Browse all side effects of Ritalin la:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paleness:

Paleness (1,551 drugs)

Browse all the conditions that are associated with Paleness:

Paleness (2,119 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Ritalin la) and Ritalin la (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.